<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03608488</url>
  </required_header>
  <id_info>
    <org_study_id>Tugbaozsoy</org_study_id>
    <nct_id>NCT03608488</nct_id>
  </id_info>
  <brief_title>The Effect of Vitamin D and Exercise on Balance in Postmenopausal Women</brief_title>
  <official_title>The Effect of Vitamin D and Exercise on Balance in Postmenopausal Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In recent years, skeletal and nonskeletal effects of vitamin D has been studied. One of the
      effects of it was balance and fall prevention. However, these studies were performed on older
      patients who had not vitamin D deficiency. This study aimed to evaluate the effect of vitamin
      D replacement therapy and exercise on balance in 50-70 years-old postmenopausal women.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 6, 2018</start_date>
  <completion_date type="Actual">July 12, 2019</completion_date>
  <primary_completion_date type="Actual">July 12, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postural Stability Test (Biodex) Assessed at Baseline</measure>
    <time_frame>Baseline</time_frame>
    <description>overall stability index: quantifying the ability to maintain dynamic postural stability The patient's score on this test assesses deviations from center, thus lower index means less instability and better balance.
Measures were obtained from 20-sec trials during which participants were asked to maintain an upright standing position on their dominant limb on the unstable surface of the Biodex Stability and Balance System.
0 is the minimum score, but there is no defined maximum score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postural Stability Test (Biodex) Assessed After Treatment (8 Weeks)</measure>
    <time_frame>After treatment (8 weeks)</time_frame>
    <description>overall stability index: quantifying the ability to maintain dynamic postural stability.
The patient's score on this test assesses deviations from center, thus a lower score is more desirable than a higher score.
Measures were obtained from 20-sec trials during which participants were asked to maintain an upright standing position on their dominant limb on the unstable surface of the Biodex Stability and Balance System 0 is the minimum score, but there is no defined maximum score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Berg Balance Test Assessed at Baseline</measure>
    <time_frame>Baseline</time_frame>
    <description>14-item scale designed to measure balance of the older adult in a clinical setting minimum: 0 maximum: 56 A score of 56 indicates functional balance. A score of &lt; 45 indicates individuals may be at greater risk of falling.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Berg Balance Test Assessed After Treatment (8weeks)</measure>
    <time_frame>After treatment (8 weeks)</time_frame>
    <description>14-item scale designed to measure balance of the older adult in a clinical setting minimum: 0 maximum: 56 A score of 56 indicates functional balance. A score of &lt; 45 indicates individuals may be at greater risk of falling.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fall Risk Assesment Performed at Baseline</measure>
    <time_frame>Baseline</time_frame>
    <description>Biodex fall risk screening test: Patients were instructed to maintain the vertical projection with their center of gravity in the midpoint of the platform 0 is the best possible value, higher score reflects increased risk of falling. But there is no defined maximum score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fall Risk Assesment Performed After Treatment (8 Weeks)</measure>
    <time_frame>After treatment (8 weeks)</time_frame>
    <description>Biodex fall risk screening test: Patients were instructed to maintain the vertical projection with their center of gravity in the midpoint of the platform 0Â° is the best possible value, higher score reflects increased risk of falling. But there is no defined maximum score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Status Assessed at Baseline</measure>
    <time_frame>Baseline</time_frame>
    <description>Notthingham Health Profile: general patient reported outcome measure which measures subjective health status.
38 questions in 6 subareas, with each question assigned a weighted value; the sum of all weighted valuesin a given subarea adds up to 100. Overall score is calculated by summing up 6 subdomian scores.
Ovearall minimum: 0 maximum: 600 (6X100) Higher scores reflect worse health status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Status Assessed After Treatment (8 Weeks)</measure>
    <time_frame>After treatment (8 weeks)</time_frame>
    <description>Notthingham Health Profile: general patient reported outcome measure which measures subjective health status.
38 questions in 6 subareas, with each question assigned a weighted value; the sum of all weighted valuesin a given subarea adds up to 100. Overall score is calculated by summing up 6 subdomian scores.
Ovearall minimum: 0 maximum: 600 (6X100) Higher scores reflect worse health status.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">110</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Vitamin D&lt;10 ng/ml; Vitamin D replacement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D replacement (50.000 IU/per week, for 8 weeks)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D&lt;10 ng/ml; Vitamin D replacement and exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D replacement (50.000 IU/per week, for 8 weeks) and Core and balance exercises for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D&lt;10 ng/ml; exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Core and balance exercises for 8 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D&gt;30ng/ml; exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Core and balance exercises for 8 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>Vitamin D3 50.000 IU/per week, for 8 weeks</description>
    <arm_group_label>Vitamin D&lt;10 ng/ml; Vitamin D replacement</arm_group_label>
    <arm_group_label>Vitamin D&lt;10 ng/ml; Vitamin D replacement and exercise</arm_group_label>
    <other_name>exercise</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Core stability, balance exercises</description>
    <arm_group_label>Vitamin D&lt;10 ng/ml; exercise</arm_group_label>
    <arm_group_label>Vitamin D&gt;30ng/ml; exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  50-70 years-old postmenopausal women

          -  Vitamin D level&lt;10 ng/ml and Vitamin D level&gt;30 ng/ml

          -  Independant in daily life

          -  Able to do exercise

          -  Able to read and write in Turkish

        Exclusion Criteria:

          -  Diabetes mellitus,

          -  Polyneuropathy,

          -  Spinal stenosis,

          -  History of fracture or lower extremity operation,

          -  Rheumatologic diseases,

          -  History of chemotherapy

          -  Cognitive impairment
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tugba Ozsoy-Unubol, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sultan Abdulhamid Han Training and Research Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sultan Abdulhamid Han Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>July 4, 2018</study_first_submitted>
  <study_first_submitted_qc>July 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 1, 2018</study_first_posted>
  <results_first_submitted>September 22, 2019</results_first_submitted>
  <results_first_submitted_qc>February 14, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 27, 2020</results_first_posted>
  <last_update_submitted>June 22, 2020</last_update_submitted>
  <last_update_submitted_qc>June 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>balance</keyword>
  <keyword>vitamin D</keyword>
  <keyword>exercise</keyword>
  <keyword>fall risk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 1, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/88/NCT03608488/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement</title>
          <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks</description>
        </group>
        <group group_id="P2">
          <title>Vitamin D&lt;10 ng/ml; Exercise</title>
          <description>Exercise: Core stability, balance exercises</description>
        </group>
        <group group_id="P3">
          <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement and Exercise</title>
          <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks and Exercise: Core stability, balance exercises</description>
        </group>
        <group group_id="P4">
          <title>Vitamin D&gt;30ng/ml; Exercise</title>
          <description>Exercise: Core stability, balance exercises</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="21"/>
                <participants group_id="P3" count="22"/>
                <participants group_id="P4" count="45"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="20"/>
                <participants group_id="P4" count="40"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
                <participants group_id="P3" count="2"/>
                <participants group_id="P4" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement</title>
          <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks</description>
        </group>
        <group group_id="B2">
          <title>Vitamin D&lt;10 ng/ml; Exercise</title>
          <description>Exercise: Core stability, balance exercises</description>
        </group>
        <group group_id="B3">
          <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement and Exercise</title>
          <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks and Exercise: Core stability, balance exercises</description>
        </group>
        <group group_id="B4">
          <title>Vitamin D&gt;30ng/ml; Exercise</title>
          <description>Exercise: Core stability, balance exercises</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="20"/>
            <count group_id="B4" value="40"/>
            <count group_id="B5" value="99"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="36"/>
                    <measurement group_id="B5" value="92"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.76" spread="5.08"/>
                    <measurement group_id="B2" value="54.66" spread="5.59"/>
                    <measurement group_id="B3" value="55.70" spread="4.84"/>
                    <measurement group_id="B4" value="58.82" spread="5.84"/>
                    <measurement group_id="B5" value="56.78" spread="5.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="40"/>
                    <measurement group_id="B5" value="99"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="40"/>
                    <measurement group_id="B5" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Turkey</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="40"/>
                    <measurement group_id="B5" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Postural Stability Test (Biodex) Assessed at Baseline</title>
        <description>overall stability index: quantifying the ability to maintain dynamic postural stability The patient's score on this test assesses deviations from center, thus lower index means less instability and better balance.
Measures were obtained from 20-sec trials during which participants were asked to maintain an upright standing position on their dominant limb on the unstable surface of the Biodex Stability and Balance System.
0 is the minimum score, but there is no defined maximum score</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks</description>
          </group>
          <group group_id="O2">
            <title>Vitamin D&lt;10 ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O3">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement and Exercise</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks and Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O4">
            <title>Vitamin D&gt;30ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
        </group_list>
        <measure>
          <title>Postural Stability Test (Biodex) Assessed at Baseline</title>
          <description>overall stability index: quantifying the ability to maintain dynamic postural stability The patient's score on this test assesses deviations from center, thus lower index means less instability and better balance.
Measures were obtained from 20-sec trials during which participants were asked to maintain an upright standing position on their dominant limb on the unstable surface of the Biodex Stability and Balance System.
0 is the minimum score, but there is no defined maximum score</description>
          <units>score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.25" spread="1.27"/>
                    <measurement group_id="O2" value="2.30" spread="0.97"/>
                    <measurement group_id="O3" value="2.18" spread="1.01"/>
                    <measurement group_id="O4" value="1.97" spread="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Postural Stability Test (Biodex) Assessed After Treatment (8 Weeks)</title>
        <description>overall stability index: quantifying the ability to maintain dynamic postural stability.
The patient's score on this test assesses deviations from center, thus a lower score is more desirable than a higher score.
Measures were obtained from 20-sec trials during which participants were asked to maintain an upright standing position on their dominant limb on the unstable surface of the Biodex Stability and Balance System 0 is the minimum score, but there is no defined maximum score</description>
        <time_frame>After treatment (8 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks</description>
          </group>
          <group group_id="O2">
            <title>Vitamin D&lt;10 ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O3">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement and Exercise</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks and Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O4">
            <title>Vitamin D&gt;30ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
        </group_list>
        <measure>
          <title>Postural Stability Test (Biodex) Assessed After Treatment (8 Weeks)</title>
          <description>overall stability index: quantifying the ability to maintain dynamic postural stability.
The patient's score on this test assesses deviations from center, thus a lower score is more desirable than a higher score.
Measures were obtained from 20-sec trials during which participants were asked to maintain an upright standing position on their dominant limb on the unstable surface of the Biodex Stability and Balance System 0 is the minimum score, but there is no defined maximum score</description>
          <units>score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.90" spread="1.20"/>
                    <measurement group_id="O2" value="1.83" spread="0.83"/>
                    <measurement group_id="O3" value="1.56" spread="0.74"/>
                    <measurement group_id="O4" value="1.43" spread="0.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Berg Balance Test Assessed at Baseline</title>
        <description>14-item scale designed to measure balance of the older adult in a clinical setting minimum: 0 maximum: 56 A score of 56 indicates functional balance. A score of &lt; 45 indicates individuals may be at greater risk of falling.</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks</description>
          </group>
          <group group_id="O2">
            <title>Vitamin D&lt;10 ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O3">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement and Exercise</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks and Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O4">
            <title>Vitamin D&gt;30ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
        </group_list>
        <measure>
          <title>Berg Balance Test Assessed at Baseline</title>
          <description>14-item scale designed to measure balance of the older adult in a clinical setting minimum: 0 maximum: 56 A score of 56 indicates functional balance. A score of &lt; 45 indicates individuals may be at greater risk of falling.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.52" spread="2.94"/>
                    <measurement group_id="O2" value="51.77" spread="1.80"/>
                    <measurement group_id="O3" value="52.35" spread="1.59"/>
                    <measurement group_id="O4" value="53.02" spread="2.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Berg Balance Test Assessed After Treatment (8weeks)</title>
        <description>14-item scale designed to measure balance of the older adult in a clinical setting minimum: 0 maximum: 56 A score of 56 indicates functional balance. A score of &lt; 45 indicates individuals may be at greater risk of falling.</description>
        <time_frame>After treatment (8 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks</description>
          </group>
          <group group_id="O2">
            <title>Vitamin D&lt;10 ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O3">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement and Exercise</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks and Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O4">
            <title>Vitamin D&gt;30ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
        </group_list>
        <measure>
          <title>Berg Balance Test Assessed After Treatment (8weeks)</title>
          <description>14-item scale designed to measure balance of the older adult in a clinical setting minimum: 0 maximum: 56 A score of 56 indicates functional balance. A score of &lt; 45 indicates individuals may be at greater risk of falling.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="53.33" spread="2.67"/>
                    <measurement group_id="O2" value="53.55" spread="1.78"/>
                    <measurement group_id="O3" value="54.25" spread="1.37"/>
                    <measurement group_id="O4" value="54.27" spread="1.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fall Risk Assesment Performed at Baseline</title>
        <description>Biodex fall risk screening test: Patients were instructed to maintain the vertical projection with their center of gravity in the midpoint of the platform 0 is the best possible value, higher score reflects increased risk of falling. But there is no defined maximum score</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks</description>
          </group>
          <group group_id="O2">
            <title>Vitamin D&lt;10 ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O3">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement and Exercise</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks and Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O4">
            <title>Vitamin D&gt;30ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
        </group_list>
        <measure>
          <title>Fall Risk Assesment Performed at Baseline</title>
          <description>Biodex fall risk screening test: Patients were instructed to maintain the vertical projection with their center of gravity in the midpoint of the platform 0 is the best possible value, higher score reflects increased risk of falling. But there is no defined maximum score</description>
          <units>score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.69" spread="1.08"/>
                    <measurement group_id="O2" value="1.96" spread="0.94"/>
                    <measurement group_id="O3" value="1.90" spread="0.98"/>
                    <measurement group_id="O4" value="1.71" spread="0.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fall Risk Assesment Performed After Treatment (8 Weeks)</title>
        <description>Biodex fall risk screening test: Patients were instructed to maintain the vertical projection with their center of gravity in the midpoint of the platform 0Â° is the best possible value, higher score reflects increased risk of falling. But there is no defined maximum score.</description>
        <time_frame>After treatment (8 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks</description>
          </group>
          <group group_id="O2">
            <title>Vitamin D&lt;10 ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O3">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement and Exercise</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks and Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O4">
            <title>Vitamin D&gt;30ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
        </group_list>
        <measure>
          <title>Fall Risk Assesment Performed After Treatment (8 Weeks)</title>
          <description>Biodex fall risk screening test: Patients were instructed to maintain the vertical projection with their center of gravity in the midpoint of the platform 0Â° is the best possible value, higher score reflects increased risk of falling. But there is no defined maximum score.</description>
          <units>score</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.40" spread="0.74"/>
                    <measurement group_id="O2" value="1.57" spread="0.69"/>
                    <measurement group_id="O3" value="1.35" spread="0.57"/>
                    <measurement group_id="O4" value="1.81" spread="2.79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health Status Assessed at Baseline</title>
        <description>Notthingham Health Profile: general patient reported outcome measure which measures subjective health status.
38 questions in 6 subareas, with each question assigned a weighted value; the sum of all weighted valuesin a given subarea adds up to 100. Overall score is calculated by summing up 6 subdomian scores.
Ovearall minimum: 0 maximum: 600 (6X100) Higher scores reflect worse health status</description>
        <time_frame>Baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks</description>
          </group>
          <group group_id="O2">
            <title>Vitamin D&lt;10 ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O3">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement and Exercise</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks and Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O4">
            <title>Vitamin D&gt;30ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
        </group_list>
        <measure>
          <title>Health Status Assessed at Baseline</title>
          <description>Notthingham Health Profile: general patient reported outcome measure which measures subjective health status.
38 questions in 6 subareas, with each question assigned a weighted value; the sum of all weighted valuesin a given subarea adds up to 100. Overall score is calculated by summing up 6 subdomian scores.
Ovearall minimum: 0 maximum: 600 (6X100) Higher scores reflect worse health status</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="263.35" spread="143.52"/>
                    <measurement group_id="O2" value="212.81" spread="137.78"/>
                    <measurement group_id="O3" value="229.98" spread="119.31"/>
                    <measurement group_id="O4" value="161.10" spread="109.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health Status Assessed After Treatment (8 Weeks)</title>
        <description>Notthingham Health Profile: general patient reported outcome measure which measures subjective health status.
38 questions in 6 subareas, with each question assigned a weighted value; the sum of all weighted valuesin a given subarea adds up to 100. Overall score is calculated by summing up 6 subdomian scores.
Ovearall minimum: 0 maximum: 600 (6X100) Higher scores reflect worse health status.</description>
        <time_frame>After treatment (8 weeks)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks</description>
          </group>
          <group group_id="O2">
            <title>Vitamin D&lt;10 ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O3">
            <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement and Exercise</title>
            <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks and Exercise: Core stability, balance exercises</description>
          </group>
          <group group_id="O4">
            <title>Vitamin D&gt;30ng/ml; Exercise</title>
            <description>Exercise: Core stability, balance exercises</description>
          </group>
        </group_list>
        <measure>
          <title>Health Status Assessed After Treatment (8 Weeks)</title>
          <description>Notthingham Health Profile: general patient reported outcome measure which measures subjective health status.
38 questions in 6 subareas, with each question assigned a weighted value; the sum of all weighted valuesin a given subarea adds up to 100. Overall score is calculated by summing up 6 subdomian scores.
Ovearall minimum: 0 maximum: 600 (6X100) Higher scores reflect worse health status.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
                <count group_id="O2" value="18"/>
                <count group_id="O3" value="20"/>
                <count group_id="O4" value="40"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="170.19" spread="120.24"/>
                    <measurement group_id="O2" value="158.23" spread="145.94"/>
                    <measurement group_id="O3" value="171.98" spread="108.18"/>
                    <measurement group_id="O4" value="119.30" spread="97.04"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse Events were not monitored/assessed</time_frame>
      <desc>Adverse Events were not monitored/assessed.</desc>
      <group_list>
        <group group_id="E1">
          <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement</title>
          <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks</description>
        </group>
        <group group_id="E2">
          <title>Vitamin D&lt;10 ng/ml; Exercise</title>
          <description>Exercise: Core stability, balance exercises</description>
        </group>
        <group group_id="E3">
          <title>Vitamin D&lt;10 ng/ml; Vitamin D Replacement and Exercise</title>
          <description>Vitamin D: Vitamin D3 50.000 IU/per week, for 8 weeks and Exercise: Core stability, balance exercises</description>
        </group>
        <group group_id="E4">
          <title>Vitamin D&gt;30ng/ml; Exercise</title>
          <description>Exercise: Core stability, balance exercises</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Tugba OZsoy-Unubol</name_or_title>
      <organization>SultanAbdulhamid</organization>
      <phone>+905074583382</phone>
      <email>tugbaozsoyy@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

